PRTA - Prothena Corporation plc
NASDAQ
->
Healthcare
->
Biotechnology
Dublin,
Ireland
Type: Equity
PRTA price evolution
PRTA
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $620.18 | $672.25 | $660.46 | $686.18 |
| Short term investments | ||||
| Net receivables | $5.16 | $5.16 | $0.52 | |
| Inventory | ||||
| Total current assets | $639.28 | $690.6 | $677.1 | $700.34 |
| Long term investments | $0.86 | $0.86 | $0.86 | $2.21 |
| Property, plant & equipment | $16 | $15.06 | $5.48 | $6.64 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $57.1 | $56.32 | $43.55 | $41.24 |
| Total investments | $0.86 | $0.86 | $0.86 | $2.21 |
| Total assets | $696.38 | $746.92 | $720.65 | $741.59 |
| Current liabilities | ||||
| Accounts payable | $25.39 | $19.46 | $13.85 | $12.52 |
| Deferred revenue | $67.41 | $67.72 | $92.53 | $94.62 |
| Short long term debt | $1.11 | $1.82 | $3.45 | $4.88 |
| Total current liabilities | $56.89 | $53.37 | $71.56 | $48.88 |
| Long term debt | $10.72 | $8.92 | ||
| Total noncurrent liabilities | $78.13 | $76.32 | $67.41 | $85.29 |
| Total debt | $11.84 | $10.73 | $3.45 | $4.88 |
| Total liabilities | $135.02 | $129.69 | $138.97 | $134.18 |
| Shareholders' equity | ||||
| Retained earnings | -$980.03 | -$912.55 | -$934.46 | -$879.87 |
| Other shareholder equity | $561.37 | |||
| Total shareholder equity | $561.37 | $617.23 | $581.68 | $607.41 |
| (in millions $) | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $620.18 | $710.41 | $579.09 | $296.73 |
| Short term investments | ||||
| Net receivables | $5.16 | $0.01 | ||
| Inventory | ||||
| Total current assets | $639.28 | $719.1 | $584.81 | $299.28 |
| Long term investments | $0.86 | $2.21 | $1.35 | $1.35 |
| Property, plant & equipment | $16 | $8.01 | $14.13 | $20.36 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $57.1 | $38.94 | $24.56 | $33.69 |
| Total investments | $0.86 | $2.21 | $1.35 | $1.35 |
| Total assets | $696.38 | $758.03 | $609.37 | $332.98 |
| Current liabilities | ||||
| Accounts payable | $25.39 | $9.27 | $3.69 | $4.12 |
| Deferred revenue | $67.41 | $96.73 | $110.59 | $110.24 |
| Short long term debt | $1.11 | $6.47 | $5.94 | $5.51 |
| Total current liabilities | $56.89 | $50.15 | $33.45 | $25.85 |
| Long term debt | $10.72 | $6.39 | $12.33 | |
| Total noncurrent liabilities | $78.13 | $85.85 | $109.87 | $123.12 |
| Total debt | $11.84 | $6.47 | $12.33 | $17.84 |
| Total liabilities | $135.02 | $135.99 | $143.32 | $148.97 |
| Shareholders' equity | ||||
| Retained earnings | -$980.03 | -$833 | -$716.05 | -$783.03 |
| Other shareholder equity | $561.37 | $466.04 | ||
| Total shareholder equity | $561.37 | $622.04 | $466.04 | $184.01 |
| (in millions $) | 31 Jan 2024 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.32 | $84.87 | $4.02 | $2.17 |
| Cost of revenue | ||||
| Gross Profit | $84.87 | $4.02 | $2.17 | |
| Operating activities | ||||
| Research & development | $57.91 | $56.01 | $44.76 | |
| Selling, general & administrative | $16.64 | $14.51 | $13.74 | |
| Total operating expenses | $78.83 | $74.56 | $70.52 | $58.49 |
| Operating income | $10.31 | -$66.5 | -$56.33 | |
| Income from continuing operations | ||||
| EBIT | $18.82 | -$58.9 | -$49.78 | |
| Income tax expense | -$3.14 | -$3.09 | -$4.31 | -$2.91 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$67.48 | $21.91 | -$54.59 | -$46.86 |
| Income (for common shares) | $21.91 | -$54.59 | -$46.86 | |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $91.37 | $53.91 | $0.85 | |
| Cost of revenue | ||||
| Gross Profit | $53.91 | $0.85 | ||
| Operating activities | ||||
| Research & development | $135.56 | $74.88 | ||
| Selling, general & administrative | $49.9 | $38.7 | ||
| Total operating expenses | $282.41 | $185.46 | $113.59 | |
| Operating income | -$131.56 | -$112.73 | ||
| Income from continuing operations | ||||
| EBIT | -$125.61 | -$111.43 | ||
| Income tax expense | -$13.45 | -$8.66 | -$0.28 | |
| Interest expense | ||||
| Net income | ||||
| Net income | -$147.03 | -$116.95 | -$111.14 | |
| Income (for common shares) | -$116.95 | -$111.14 | ||
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | -$67.48 | $21.91 | -$54.59 | -$46.86 |
| Operating activities | ||||
| Depreciation | $2.54 | $2.31 | $1.8 | $1.76 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $11.08 | $10.94 | $10.1 | $8.79 |
| Total cash flows from operations | -$51.04 | $9.52 | -$44.93 | -$47.46 |
| Investing activities | ||||
| Capital expenditures | -$1.51 | -$0.44 | -$0.77 | -$0.05 |
| Investments | ||||
| Total cash flows from investing | -$1.51 | -$0.44 | -$0.77 | -$0.05 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.48 | $2.71 | $18.63 | $23.28 |
| Net borrowings | ||||
| Total cash flows from financing | $0.48 | $2.71 | $18.63 | $23.28 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$52.07 | $11.79 | -$27.07 | -$24.22 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$147.03 | -$116.95 | $66.97 | -$111.14 |
| Operating activities | ||||
| Depreciation | $8.41 | $6.74 | $6.8 | $6.98 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $40.91 | $31.32 | $24.66 | $22.01 |
| Total cash flows from operations | -$133.91 | -$108.82 | $92.61 | -$80.36 |
| Investing activities | ||||
| Capital expenditures | -$2.77 | -$0.46 | -$0.57 | -$0.2 |
| Investments | ||||
| Total cash flows from investing | -$2.77 | -$0.46 | -$0.57 | -$0.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $45.1 | $241.46 | $190.33 | $0.21 |
| Net borrowings | ||||
| Total cash flows from financing | $45.1 | $241.46 | $190.33 | $0.21 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$91.58 | $132.17 | $282.36 | -$80.34 |
News
Fundamentals
| Market cap | $1.10B |
|---|---|
| Enterprise value | $496.26M |
| Shares outstanding | 53.70M |
| Revenue | $91.37M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$147.03M |
| Revenue Q/Q | -99.37% |
| Revenue Y/Y | 69.50% |
| P/E ratio | -7.51 |
|---|---|
| EV/Sales | 5.43 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 12.09 |
| P/B ratio | InfinityT |
| Book/Share | 0.00 |
| Cash/Share | 11.55 |
| EPS | -$2.74 |
|---|---|
| ROA | -20.24% |
| ROE | -24.84% |
| Debt/Equity | 0.24 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 11.24 |
| Quick ratio | 11.24 |